Leukemias Epidemiological Global Forecast
Size markets and assess market potential on a global scale with DRG’s gold-standard epidemiology. DRG epidemiology has the depth and breadth required for accurate market sizing, with 3,400+ patient segmentations across 140+ disease and 40+ countries.
This report will answer the following key questions:
- How many people worldwide will be diagnosed with acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) or Chronic myeloid leukemia (CML) in 2017, and how will this number change over the coming decade, and what factors will be driving the change?
- Which world regions have the greatest number of people diagnosed with AML or ALL or CML in 2017, and which region will show the greatest growth in cases over the coming decade?
- We report numbers for important subpopulations based on cytogenetics, mutations and which affect therapy and prognosis of Leukemia cases.